Capsicum.

Capsaicinoids activate TRPV1 on sensory nerves, which triggers catecholamine release and a rise in resting energy expenditure. Caffeine acts downstream by blocking adenosine receptors and slowing cyclic AMP breakdown, so the two steps are additive rather than duplicated.

Capsicum raises sympathetic noradrenaline release through TRPV1, and green tea catechins inhibit catechol-O-methyltransferase, the enzyme that clears noradrenaline. One releases the signal, the other slows its breakdown.

Piperine and capsaicin are both TRPV1 agonists, so they act at the same sensory receptor. Piperine additionally inhibits intestinal metabolising enzymes, which is the reason it is added to pungent-principle blends.

Capsaicin activates TRPV1 and gingerols activate the same and neighbouring TRP channels, the shared route behind warming sensation and raised thermogenesis. Two agonists of one channel family, differing in potency and duration.

Capsaicin raises catecholamine signalling that releases fatty acids from stores, and carnitine carries long-chain fatty acids across the mitochondrial membrane where they are burned. Mobilisation and transport are consecutive steps.

Tyrosine is the amino acid precursor of dopamine, noradrenaline and adrenaline, the catecholamines capsaicin's TRPV1 signalling calls on. Supplying the substrate supports the pathway the botanical stimulates.

Capsaicin raises catecholamine release, which acts through beta-adrenergic receptors, while forskolin activates adenylate cyclase directly downstream of those receptors. The pair addresses the same cyclic AMP cascade at two points.

Salicin-derived salicylate reduces the prostaglandins that maintain gastric mucus and bicarbonate, while capsaicin is a direct TRPV1 irritant at higher doses. Stacked in one capsule the burden on the stomach lining adds up.

Capsaicin and dihydrocapsaicin are poorly water soluble and dissolve readily in triglyceride, which is why oleoresin is an oil based ingredient and why milk fat rather than water quiets the burn. A lipid carrier keeps the capsaicinoids dispersed through a dosage form and supports their passage into micelles in the gut. This concerns delivery, not any body outcome.

Lecithin emulsifies an oleoresin so it distributes evenly in a powder, beverage or softgel rather than separating or sticking to equipment. Even dispersion also makes capsaicinoid content per dose more consistent. The role is physical, and it says nothing about potency in a person.

Curcumin and capsaicinoids are both poorly water soluble molecules that end up in the same lipid phase of a formulation, so they share carriers and stability concerns. Both also interact with transient receptor potential channels on sensory nerve endings, curcumin more weakly. The pairing is common in spice blends and the mechanistic overlap is described, but combination evidence in people is thin.

Cinnamaldehyde and capsaicin act on different members of the same sensory channel family, TRPA1 and TRPV1 respectively, which is why they turn up together in warming spice blends. The only combination work in the candidate set is a dairy cattle feeding study of a three component blend, so it grounds the co-formulation and not a human effect. Early is the correct label and any human read across would be speculation.

Menthol acts at the cold sensing TRPM8 channel and capsaicin at the heat sensing TRPV1 channel, so the two produce opposing thermal sensations on the same tissue. In topical products that opposition is used deliberately. Taken orally, both can add to gastric and oesophageal sensitivity in people prone to it. Direction of the sensory interaction is well described, the net effect in a given product is not.

Mucilage forming botanicals coat mucosal surfaces and are used where a preparation is irritating on the way down. That gives a plausible reason to combine one with a capsaicinoid dose, though nothing in the literature here tests the pair. Enteric coating is the more common formulation answer to the same problem.

Marshmallow root mucilage forms a viscous layer over mucosal tissue, a property used where an ingredient causes a warming or scratching sensation. Pairing it with capsaicinoids follows that logic rather than any tested result. Its viscosity can also slow uptake of whatever is taken with it, which cuts both ways.

Activated charcoal binds lipophilic plant compounds without discrimination, so a dose taken with a capsaicinoid extract can carry part of it out of the gut. Nothing here measures the loss for capsaicin specifically. Charcoal is dosed away from any ingredient meant to be absorbed.

Rosemary extract supplies carnosic acid and related diterpenes that slow oxidation of the oil phase carrying an oleoresin. Colour and pungency of paprika and chilli extracts fade with oxidation and light, so an antioxidant protects declared capsaicinoid content over shelf life. This is stability work, not a physiological pairing.

Mixed tocopherols interrupt lipid radical chains in the oil that carries capsaicinoids and carotenoid pigments, which is why they appear on oleoresin softgel labels. The benefit is to the product rather than to the person taking it. Tocopherols are consumed as they work, so the protection is finite.

Topical preparations aimed at joint comfort and mobility often carry both a capsaicinoid and MSM, and the two are combined by convention rather than by any demonstrated interaction. No candidate evidence here tests them together. The row records the pairing so a formulator sees it, at Early confidence.